155 related articles for article (PubMed ID: 23267001)
1. Case report: Death in the emergency department: an unrecognized awake malignant hyperthermia-like reaction in a six-year-old.
Lavezzi WA; Capacchione JF; Muldoon SM; Sambuughin N; Bina S; Steele D; Brandom BW
Anesth Analg; 2013 Feb; 116(2):420-3. PubMed ID: 23267001
[TBL] [Abstract][Full Text] [Related]
2. [Malignant hyperthermia].
Glahn KP
Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
[TBL] [Abstract][Full Text] [Related]
3. Malignant hyperthermia.
Rosenberg H; Davis M; James D; Pollock N; Stowell K
Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235
[TBL] [Abstract][Full Text] [Related]
4. Volatile anesthetics and succinylcholine in cardiac ryanodine receptor defects.
Swan H; Laitinen PJ; Toivonen L
Anesth Analg; 2004 Aug; 99(2):435-7, table of contents. PubMed ID: 15271719
[TBL] [Abstract][Full Text] [Related]
5. A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibility.
Taylor A; Lachlan K; Manners RM; Lotery AJ
J Clin Neurosci; 2012 Jan; 19(1):65-70. PubMed ID: 22030266
[TBL] [Abstract][Full Text] [Related]
6. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
Brandom BW; Muldoon SM
Paediatr Anaesth; 2013 Sep; 23(9):851-4. PubMed ID: 23848295
[TBL] [Abstract][Full Text] [Related]
7. Core myopathies and malignant hyperthermia susceptibility: a review.
Brislin RP; Theroux MC
Paediatr Anaesth; 2013 Sep; 23(9):834-41. PubMed ID: 23617272
[TBL] [Abstract][Full Text] [Related]
8. [Masseter muscle rigidity after suxamethonium during induction and postoperative abortive malignant hyperthermia in a patient with esophageal achalasia].
Arakawa Y; Kuroiwa M; Anzai T; Kanai A; Okamoto H; Hoka S
Masui; 2004 Mar; 53(3):287-90. PubMed ID: 15071881
[TBL] [Abstract][Full Text] [Related]
9. [Malignant hyperthermia].
Bouhajja B; Haddad F; Ben Ammar MS
Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic testing to diagnose malignant hyperthermia susceptibility.
Girard T; Litman RS
J Clin Anesth; 2008 May; 20(3):161-3. PubMed ID: 18502356
[No Abstract] [Full Text] [Related]
11. Multiminicore myopathy, central core disease, malignant hyperthermia susceptibility, and RYR1 mutations: one disease with many faces?
Mathews KD; Moore SA
Arch Neurol; 2004 Jan; 61(1):27-9. PubMed ID: 14732615
[No Abstract] [Full Text] [Related]
12. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
McCarthy TV; Quane KA; Lynch PJ
Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
[TBL] [Abstract][Full Text] [Related]
13. Recognizing and treating malignant hyperthermia.
Corvetto MA; Taekman JM
Simul Healthc; 2010 Jun; 5(3):169-72. PubMed ID: 20651479
[No Abstract] [Full Text] [Related]
14. Masseter muscle rigidity, elevated creatine kinase, and rhabdomyolysis following succinylcholine administration: a case report.
Fitzpatrick LR
AANA J; 2008 Oct; 76(5):349-54. PubMed ID: 18947162
[TBL] [Abstract][Full Text] [Related]
15. The importance of a prepared and ready malignant hyperthermia response team.
Rosen GP; Escobar M; Fumero P; Viswanath O; Wright J
J Clin Anesth; 2019 Sep; 56():109-110. PubMed ID: 30743151
[No Abstract] [Full Text] [Related]
16. Case of leptosuccin induced malignant hyperthermia in a patient with GIST of the rectum.
Natasa N; Snezana P; Nemanja Z; Zoran K; Durasić L
Acta Chir Iugosl; 2012; 59(2):121-3. PubMed ID: 23373371
[TBL] [Abstract][Full Text] [Related]
17. Masseter spasm after succinylcholine administration.
Gill M; Graeme K; Guenterberg K
J Emerg Med; 2005 Aug; 29(2):167-71. PubMed ID: 16029828
[TBL] [Abstract][Full Text] [Related]
18. Succinylcholine-induced masseter muscle rigidity during bronchoscopic removal of a tracheal foreign body.
Maghsoudi B; Khademi B
Int J Pediatr Otorhinolaryngol; 2005 Sep; 69(9):1283-5. PubMed ID: 15893386
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia: description and case report.
Gohil P; Forman WM
J Foot Surg; 1982; 21(1):7-11. PubMed ID: 7069146
[No Abstract] [Full Text] [Related]
20. Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease.
Vukcevic M; Broman M; Islander G; Bodelsson M; Ranklev-Twetman E; Müller CR; Treves S
Anesth Analg; 2010 Jul; 111(1):185-90. PubMed ID: 20142353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
